COMPANY
Tixel
Formerly known as Novoxel®.
A global medical technology company advancing the TMA® platform across dermatology, aesthetics, and ophthalmology.
MISSION
Medical innovation that leads the industry in safe results and patient satisfaction.
ABOUT THE COMPANY
Clinical platform, built with physicians
Tixel is the next generation of energy-based technology, built on over a decade of scientific and clinical innovation.
Established in 2011 as Novoxel Ltd., the company has pioneered Thermo-Mechanical Action (TMA) — a patented technology that delivers pure thermal energy directly to the skin, and is used around the world, including USA, Canada, EU, UK, Australia, Japan, Brazil and Korea.
The Tixel family of products provides safe, non-invasive, and radiation-free treatments with minimal downtime — without bleeding, significant pain, or costly single-use cartridges — delivering noticeable clinical results in skin rejuvenation and dry-eye care worldwide.
CORE PILLARS
- Patented TMA® platformThermo-Mechanical Action (TMA) delivers pure thermal energy directly to the skin.
- Safety profileNon-invasive, radiation-free treatments designed for minimal downtime.
- Global adoptionUsed worldwide, including USA, Canada, EU, UK, Australia, Japan, Brazil and Korea.
- Clinical indicationsSkin rejuvenation and dry-eye care, with noticeable clinical results.
- Operational efficiencyMinimal downtime without bleeding, significant pain, or costly single-use cartridges.
INTELLECTUAL PROPERTY
Protected innovation, built to last
Our Thermo-Mechanical Action (TMA)® platform is backed by a global IP strategy spanning patents, designs, and trademarks—supporting long-term R&D investment and protecting the integrity of the technology in the market.
Medical Advisory Board
Our advisory board brings frontline clinical perspective to platform development, protocol refinement, and evidence priorities—helping keep Tixel aligned with physician standards and patient safety.
Vision
(Alphabetical)
Dr. Reiko Arita M.D, PhD.
Japan
Dr. Ludger Hanneken, M.D., PhD.
Andorra
Dr. Ehud Reich, M.D.
Israel
Prof. Sunil Shah, MD
UK
Aesthetics
(Alphabetical)
Prof. Ofir Artzi
Israel
Dr. Christine Dierickx
Luxembourg
Prof. Merete Haedersdal
Denmark
Prof. Assi Levi
Israel
Dr. Victor Ross
USA
Dr. Steven Weiner
USA
Management
An experienced leadership team spanning strategy, engineering, clinical affairs, and regulatory/quality—built for long-term, global execution.
Yoni Shavit
CEO
Evgeny Piven
Israel President & COO
Eithan Shavit
USA President & CPO
Ziv Shabat
CTO
Jeff Knight
VP of Business Development
Ifat Klein, Ph.D.
VP of Clinical Affairs
Daniela Dov Elmaz
VP of RA & QA
Amy Easterly
Head of Marketing
Sixten Hofmann
Germany President